Endocr J
Sustained ReleaseThe patch provides up to 24 hours of active ingredient release throughout the day, which is convenient and practical
These medications are designed to be effective when injected into any of the approved subcutaneous sites, with product information confirming no clinically relevant differences in medication exposure between the recommended injection areas
Research Article - (2021) Volume 12, Issue 3 Diabetes prevalence is increasing, according to the International Diabetes Federation report in 2013, 382 Millions have diabetes, and the number is expected to rise beyond 592 million by 2035, an increase of approximately 55%
Cusi K, Isaacs S, Barb D, Basu R, Caprio S, Garvey WT, Kashyap S, Mechanick JI, Mouzaki M, Nadolsky K, Rinella ME, Vos MB, Younossi Z
Type 2 diabetes in adults: management NG28 Initial medicines chapter